HIV Screening for Women in Prenatal Care
Among women enrolled in Medicaid and insured privately, prenatal screening for syphilis and and hepatitis B were over 96% while screening for HIV was approximately 82% for women on Medicaid and approximately 85% for privately-insured women. In addition, screening for chlamydia and gonorrhea varied depending on whether the woman was insured with Medicaid or another commercial insurance. Overall, chlamydia screening was determined to be below recommended rates and was mostly done in conjunction with Pap testing.
Citation:
Ross CE, Tao G, Patton M, Hoover KW. Screening for human immunodeficiency virus and other sexually transmitted diseases among U.S. women with prenatal care. Obstet Gynecol. 2015 May;125(5):1211-6.
Original Article (subscription may be required)
